DNA合成儀市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶、規模、自動化程度和地區分類－2026-2033年產業預測

2024 年全球 DNA 合成設備市場價值為 6.8 億美元，預計到 2025 年將成長至 7.8 億美元，到 2033 年將成長至 22.3 億美元，在預測期（2026-2033 年）內複合年成長率為 14.1%。

全球DNA合成設備市場正推動生物技術創新，其動力源自於對客製化寡核苷酸和合成基因需求的激增。該市場涵蓋了從頭DNA合成自動化所需的關鍵設備和試劑，為從基礎研究到治療和工業應用等廣泛領域的科研人員提供支援。該平台能夠實現基因編輯、疫苗生產和合成DNA的生物製造，從而縮短專案週期並降低成本。多年來，隨著從手工合成向高通量合成儀和雲端訂購系統的轉變，該行業的產能不斷擴大。新型合成儀中改進的錯誤校正能力，推動了製藥研發公司和合約生產機構（CMO）對更長核苷酸序列的需求成長，而這些序列對於基因治療和疫苗原型設計至關重要。這種成長吸引了對擴大產能和自動化工作流程的投資，同時，學術研究機構也擴大採用內部DNA合成能力。

全球DNA合成設備市場按產品類型、技術、應用、最終用戶、規模、自動化程度和地區進行細分。依產品類型分類，市場分為桌上型DNA合成儀、高通量DNA合成儀、可攜式DNA合成儀及其他類型。依技術分類，市場包括亞磷醯胺合成、基於微陣列的合成和酶促DNA合成。按應用分類，市場包括合成生物學、基因合成、PCR引子合成、DNA定序、藥物研發和其他領域。按最終用戶分類，市場包括生物技術公司、製藥公司、學術和研究機構、合約研究組織（CRO）和診斷檢測實驗室。依規模分類，市場分為研究規模和商業規模。依自動化程度分類，市場分為全自動和半自動。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球DNA合成設備市場的成長要素

全球DNA合成設備市場正蓬勃發展，這主要得益於自動化工作流程和整合合成技術的進步。這些技術提高了通量穩定性，同時最大限度地減少了人工干預。這種簡化顯著降低了DNA合成設備的操作複雜性，確保不同專業水平的負責人都能可靠地使用這些設備。因此，越來越多的使用者開始在專業實驗室以外的環境中採用DNA合成設備。操作的簡化和合成流程的標準化正在鼓勵科研和工業領域對DNA合成設備進行更多投資，從而擴大其在全球範圍內的應用範圍。

全球DNA合成設備市場的限制因素

全球DNA合成設備市場面臨許多限制因素，主要源自於先進設備的引進與維護高成本。小規模學術研究機構和新興創業公司預算有限，往往因耗材和定期校準等高昂成本而猶豫不決。因此，許多機構選擇與第三方供應商合作，而不是自行建立相關能力，這阻礙了新技術進入市場。此外，高昂的擁有成本也促使買家要求獲得足夠的投資回報，從而延長了採購流程，降低了他們採用新型號的意願。

全球DNA合成設備市場趨勢

全球DNA合成設備市場正呈現出顯著的平台整合趨勢，不僅提升了生命科學研究人員、小規模生物技術公司和臨床服務供應商等更廣泛用戶的使用體驗，也使得更多用戶能夠受益。透過將各種合成流程整合到使用者友好的應用程式中，該產業正利用標準化的試劑介面、模組化硬體和直覺的軟體系統來降低技術門檻。這種轉變使得那些缺乏大規模專業基礎設施的機構也能利用基因合成能力，加速實驗發展並促進協作使用。隨著對易用性、互通性和可靠服務交付的重視程度不斷提高，研究和治療方法發現的方式正在發生重塑，進而推動市場擴張和創新。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球DNA合成儀市場規模：依產品類型分類

• 桌上型DNA合成機
• 高通量DNA合成系統
• 可攜式DNA合成儀
• 其他

全球DNA合成儀市場規模：依技術分類

• 亞磷醯胺合成
• 基於微陣列的合成
• 酶促DNA合成

全球DNA合成儀市場規模：依應用領域分類

• 合成生物學
• 基因合成
• PCR引子合成
• DNA定序
• 藥物發現
• 其他

全球DNA合成儀市場規模：依最終用戶分類

• 生技公司
• 製藥公司
• 學術研究機構
• 受託研究機構（CRO）
• 診斷檢查室

全球DNA合成儀市場規模：依市場規模分類

• 調查量表
• 商業規模

全球DNA合成儀市場規模：依自動化程度分類

• 全自動
• 半自動

全球DNA合成儀市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• BioAutomation Corporation
• DNA Script
• Twist Bioscience
• Codex DNA
• Kilobaser
• Synbio Technologies
• Bioneer Corporation
• LGC Biosearch Technologies
• K&A Labs
• Hongene Biotech
• GenScript Biotech
• Eurofins Genomics
• Integrated DNA Technologies
• CEM Corporation
• Biolytic Lab Performance
• Polygen GmbH
• Nitto Denko Avecia

結論與建議

Global Dna Synthesizer Market size was valued at USD 680.00 Million in 2024 and is poised to grow from USD 780.00 Million in 2025 to USD 2230.00 Million by 2033, growing at a CAGR of 14.1% during the forecast period (2026-2033).

The global DNA synthesizer market is driven by surging demand for custom oligonucleotides and synthetic genes, fostering innovations in biotechnology. This market encompasses instruments and reagents essential for automating de novo DNA synthesis, empowering researchers in areas ranging from fundamental studies to therapeutic and industrial applications. The platform facilitates gene editing, vaccine production, and synthetic DNA bio-manufacturing, thereby accelerating project timelines and reducing costs. Over time, the evolution from manual synthesis to high-throughput synthesizers and cloud-based ordering has increased industry capacity. Enhanced error correction in new synthesizers is elevating demand from pharmaceutical developers and CMOs for longer nucleotide sequences, essential for gene therapy and vaccine prototyping. This growth is attracting investor funding for capacity expansion and automated workflows, while academic labs increasingly adopt in-house DNA synthesis capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Synthesizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dna Synthesizer Market Segments Analysis

Global dna synthesizer market is segmented by product type, technology, application, end user, scale, automation level and region. Based on product type, the market is segmented into benchtop DNA synthesizers, high-throughput DNA synthesizers, portable DNA synthesizers and others. Based on technology, the market is segmented into phosphoramidite synthesis, microarray-based synthesis and enzymatic DNA synthesis. Based on application, the market is segmented into synthetic biology, gene synthesis, PCR primer synthesis, DNA sequencing, drug discovery and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical companies, academic & research institutes, contract research organizations (CROs) and diagnostic laboratories. Based on scale, the market is segmented into research scale and commercial scale. Based on automation level, the market is segmented into fully automated and semi-automated. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Dna Synthesizer Market

The Global DNA Synthesizer market is experiencing growth driven by advancements in automated workflows and integrated synthesis technologies, which minimize the need for manual intervention while enhancing throughput consistency. This simplification has significantly reduced the complexities associated with operating DNA synthesizers, allowing personnel with varying levels of expertise to use these devices with reliability. As a result, there is a growing opportunity for new users to incorporate DNA synthesizers in settings beyond specialized laboratories. By facilitating easier operations and standardizing synthesis processes, the research and industrial sectors are motivated to invest more in DNA synthesizers, thereby expanding their applications worldwide.

Restraints in the Global Dna Synthesizer Market

The global DNA synthesizer market faces significant restraints primarily due to the high costs associated with the acquisition and maintenance of advanced equipment. Small academic laboratories and emerging startups, often operating on tight budgets, are deterred from utilizing these sophisticated synthesizers due to their expense, including consumables and the need for periodic calibrations. Consequently, many organizations opt to collaborate with third-party providers instead of developing in-house capabilities, which hampers the introduction of new technologies into the market. Additionally, the substantial cost of ownership compels buyers to seek substantial returns on their investments, leading to longer procurement processes and reduced enthusiasm for acquiring new models.

Market Trends of the Global Dna Synthesizer Market

The Global DNA Synthesizer market is witnessing a significant trend towards platform integration, which is enhancing accessibility for a broader range of users, including life sciences researchers, small biotech firms, and clinical service providers. By consolidating various synthesis processes into user-friendly applications, the industry is lowering technical barriers through standardized reagent interfaces, modular hardware, and intuitive software systems. This shift enables entities without extensive specialized infrastructure to leverage gene synthesis capabilities, facilitating quicker experimental development and collaborative sharing. The growing emphasis on ease-of-use, interoperability, and robust service delivery is reshaping research and therapeutic discovery, thereby driving market expansion and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global DNA Synthesizer Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Benchtop DNA Synthesizers
• High-Throughput DNA Synthesizers
• Portable DNA Synthesizers
• Others

Global DNA Synthesizer Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Phosphoramidite Synthesis
• Microarray-Based Synthesis
• Enzymatic DNA Synthesis

Global DNA Synthesizer Market Size by Application & CAGR (2026-2033)

• Market Overview
• Synthetic Biology
• Gene Synthesis
• PCR Primer Synthesis
• DNA Sequencing
• Drug Discovery
• Others

Global DNA Synthesizer Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Diagnostic Laboratories

Global DNA Synthesizer Market Size by Scale & CAGR (2026-2033)

• Market Overview
• Research Scale
• Commercial Scale

Global DNA Synthesizer Market Size by Automation Level & CAGR (2026-2033)

• Market Overview
• Fully Automated
• Semi-Automated

Global DNA Synthesizer Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End User, Scale, Automation Level)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User, Scale, Automation Level)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User, Scale, Automation Level)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User, Scale, Automation Level)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User, Scale, Automation Level)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAutomation Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Script
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codex DNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kilobaser
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• K&A Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hongene Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolytic Lab Performance
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polygen GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nitto Denko Avecia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations